These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 19447633)
41. Models for estimation of the (10)B concentration after BPA-fructose complex infusion in patients during epithermal neutron irradiation in BNCT. Ryynänen PM; Kortesniemi M; Coderre JA; Diaz AZ; Hiismäki P; Savolainen SE Int J Radiat Oncol Biol Phys; 2000 Nov; 48(4):1145-54. PubMed ID: 11072174 [TBL] [Abstract][Full Text] [Related]
42. Effects of l-DOPA pre-loading on the uptake of boronophenylalanine using the F98 glioma and B16 melanoma models. Yang W; Barth RF; Huo T; Kabalka GW; Shaikh AL; Haider SA; Chandra S Appl Radiat Isot; 2014 Jun; 88():69-73. PubMed ID: 24485949 [TBL] [Abstract][Full Text] [Related]
43. Molecular targeting of the epidermal growth factor receptor for neutron capture therapy of gliomas. Barth RF; Yang W; Adams DM; Rotaru JH; Shukla S; Sekido M; Tjarks W; Fenstermaker RA; Ciesielski M; Nawrocky MM; Coderre JA Cancer Res; 2002 Jun; 62(11):3159-66. PubMed ID: 12036929 [TBL] [Abstract][Full Text] [Related]
44. Optimization of boron neutron capture therapy for the treatment of undifferentiated thyroid cancer. Dagrosa MA; Thomasz L; Longhino J; Perona M; Calzetta O; Blaumann H; Rebagliati RJ; Cabrini R; Kahl S; Juvenal GJ; Pisarev MA Int J Radiat Oncol Biol Phys; 2007 Nov; 69(4):1059-66. PubMed ID: 17967301 [TBL] [Abstract][Full Text] [Related]
45. Boronated epidermal growth factor as a delivery agent for neutron capture therapy of EGF receptor positive gliomas. Yang W; Barth RF; Wu G; Bandyopadhyaya AK; Thirumamagal BT; Tjarks W; Binns PJ; Riley K; Patel H; Coderre JA; Ciesielski MJ; Fenstermaker RA Appl Radiat Isot; 2004 Nov; 61(5):981-5. PubMed ID: 15308179 [TBL] [Abstract][Full Text] [Related]
46. Response of rat skin to boron neutron capture therapy with p-boronophenylalanine or borocaptate sodium. Morris GM; Coderre JA; Hopewell JW; Micca PL; Rezvani M Radiother Oncol; 1994 Aug; 32(2):144-53. PubMed ID: 7972908 [TBL] [Abstract][Full Text] [Related]
47. Selective uptake of p-borophenylalanine by undifferentiated thyroid carcinoma for boron neutron capture therapy. Dagrosa MA; Viaggi M; Kreimann E; Farías S; Garavaglia R; Agote M; Cabrini RL; Dadino JL; Juvenal GJ; Pisarev MA Thyroid; 2002 Jan; 12(1):7-12. PubMed ID: 11838734 [TBL] [Abstract][Full Text] [Related]
49. MicroPET-based pharmacokinetic analysis of the radiolabeled boron compound [18F]FBPA-F in rats with F98 glioma. Chen JC; Chang SM; Hsu FY; Wang HE; Liu RS Appl Radiat Isot; 2004 Nov; 61(5):887-91. PubMed ID: 15308163 [TBL] [Abstract][Full Text] [Related]
50. Effect of boron neutron capture therapy for melanotic and amelanotic melanoma transplanted into mouse brain. Iwakura M; Kondoh H; Hiratsuka J; Ehara K; Tamaki N; Mishima Y Pigment Cell Res; 2002 Feb; 15(1):67-75. PubMed ID: 11837459 [TBL] [Abstract][Full Text] [Related]
51. Combination of boron neutron capture therapy and external beam radiotherapy for brain tumors. Barth RF; Grecula JC; Yang W; Rotaru JH; Nawrocky M; Gupta N; Albertson BJ; Ferketich AK; Moeschberger ML; Coderre JA; Rofstad EK Int J Radiat Oncol Biol Phys; 2004 Jan; 58(1):267-77. PubMed ID: 14697448 [TBL] [Abstract][Full Text] [Related]
52. Uptake of 4-borono-2-[18F]fluoro-L-phenylalanine in sporadic and neurofibromatosis 2-related schwannoma and meningioma studied with PET. Havu-Aurén K; Kiiski J; Lehtiö K; Eskola O; Kulvik M; Vuorinen V; Oikonen V; Vähätalo J; Jääskeläinen J; Minn H Eur J Nucl Med Mol Imaging; 2007 Jan; 34(1):87-94. PubMed ID: 16896669 [TBL] [Abstract][Full Text] [Related]
53. L-Phenylalanine preloading reduces the (10)B(n, α)(7)Li dose to the normal brain by inhibiting the uptake of boronophenylalanine in boron neutron capture therapy for brain tumours. Watanabe T; Tanaka H; Fukutani S; Suzuki M; Hiraoka M; Ono K Cancer Lett; 2016 Jan; 370(1):27-32. PubMed ID: 26455769 [TBL] [Abstract][Full Text] [Related]
54. The effect of dexamethasone on the uptake of p-boronophenylalanine in the rat brain and intracranial 9L gliosarcoma. Morris GM; Micca PL; Coderre JA Appl Radiat Isot; 2004 Nov; 61(5):917-21. PubMed ID: 15308168 [TBL] [Abstract][Full Text] [Related]
55. Delivery of (10)boron to oral squamous cell carcinoma using boronophenylalanine and borocaptate sodium for boron neutron capture therapy. Obayashi S; Kato I; Ono K; Masunaga S; Suzuki M; Nagata K; Sakurai Y; Yura Y Oral Oncol; 2004 May; 40(5):474-82. PubMed ID: 15006618 [TBL] [Abstract][Full Text] [Related]
56. Boron neutron capture therapy of brain tumors: enhanced survival following intracarotid injection of sodium borocaptate with or without blood-brain barrier disruption. Yang W; Barth RF; Rotaru JH; Moeschberger ML; Joel DD; Nawrocky MM; Goodman JH; Soloway AH Int J Radiat Oncol Biol Phys; 1997 Feb; 37(3):663-72. PubMed ID: 9112465 [TBL] [Abstract][Full Text] [Related]
57. Biodistribution of GB-10 (Na(2)(10)B10H10 compound for boron neutron capture therapy (BNCT) in an experimental model of oral cancer in the hamster cheek pouch. Heber E; Trivillin VA; Nigg D; Kreimann EL; Itoiz ME; Rebagliati RJ; Batistoni D; Schwint AE Arch Oral Biol; 2004 Apr; 49(4):313-24. PubMed ID: 15003550 [TBL] [Abstract][Full Text] [Related]
58. Early clinical trial concept for boron neutron capture therapy: a critical assessment of the EORTC trial 11001. Wittig A; Collette L; Moss R; Sauerwein WA Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S59-62. PubMed ID: 19372041 [TBL] [Abstract][Full Text] [Related]
59. Early effect of boron neutron capture therapy mediated by boronophenylalanine (BPA-BNCT) on mast cells in premalignant tissue and tumors of the hamster cheek pouch. Aromando RF; Trivillin VA; Heber EM; Pozzi E; Schwint AE; Itoiz ME Oral Oncol; 2010 May; 46(5):355-9. PubMed ID: 20308008 [TBL] [Abstract][Full Text] [Related]
60. Biodistribution of p-boronophenylalanine in patients with glioblastoma multiforme for use in boron neutron capture therapy. Elowitz EH; Bergland RM; Coderre JA; Joel DD; Chadha M; Chanana AD Neurosurgery; 1998 Mar; 42(3):463-8; discussion 468-9. PubMed ID: 9526978 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]